Assessing Modern AI-Driven Protein-Ligand Modeling with Phenethylamine and Tryptamine Psychedelics
AI Chemistry · 2026
DOI: 10.3390/aichem1010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI Chemistry, 2026. Verfasst von Benjamin R. Cummins und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2A Biosciences, New York, USA.
Abstract (Originalsprache)
Modern advances in artificial intelligence have accelerated the development of computational tools for protein–ligand structure prediction, yet their real-world performance remains uneven across receptor classes and ligand chemotypes. Recently published cryo-EM structures of several different psychedelics bound to the serotonin 5HT2A receptor provide a unique opportunity to explore how modern AI-based modeling performs in a pharmacologically important GPCR system. Here, we compare three major approaches: AI-based protein–ligand cofolding (Boltz-2), a leading AI-driven docking module (Uni-Mol Docking v2), and a widely used classical physics-based docking pipeline (AutoDock Vina) across a series of tryptamine and phenethylamine psychedelics. Predicted binding poses were comparatively assessed through structural alignment with these newly available cryo-EM complexes. Additionally, calcium-mobilization assays were performed to provide a coarse functional readout for comparison with computationally predicted binding affinities. This study integrates methodological review with exploratory benchmarking to illustrate how different modeling paradigms behave on a shared receptor–ligand test set. Our results highlight substantial variation between modeling strategies, with AI-based cofolding often producing global binding orientations more closely resembling experimental structures, and classical docking showing greater variability across ligands, while still outperforming AI-driven docking on average. These observations underscore both the growing utility and current limitations of AI-assisted structure prediction in serotonergic drug discovery, and emphasize the importance of careful, experimentally anchored evaluation as such tools continue to advance.
Förderung
- 2A Biosciences, New York, USA
Zitieren
APA
Cummins, B. R., & Nichols, C. D. (2026). Assessing Modern AI-Driven Protein-Ligand Modeling with Phenethylamine and Tryptamine Psychedelics. AI Chemistry. https://doi.org/10.3390/aichem1010004
Vancouver
Cummins BR, Nichols CD. Assessing Modern AI-Driven Protein-Ligand Modeling with Phenethylamine and Tryptamine Psychedelics. AI Chemistry. 2026. doi:10.3390/aichem1010004
BibTeX
@article{Cummins2026,
author = {Cummins, Benjamin R. and Nichols, Charles D.},
title = {Assessing Modern AI-Driven Protein-Ligand Modeling with Phenethylamine and Tryptamine Psychedelics},
journal = {AI Chemistry},
year = {2026},
doi = {10.3390/aichem1010004}
}
EUVIMED